CTNNB1 and T-cell acute lymphoblastic leukemia: FAT1 has been reported recurrently mutated across multiple types of cancers, including T-cell acute lymphoblastic leukemia [27] and it appears to potently suppress cancer cell growth by binding beta-catenin and antagonizing the nuclear localization.